Related Experiment Video
Updated: Jan 18, 2026

04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
Patient and physician perceptions of a hypercholesterolemia safety-net program
Teresa N Harrison, Matt Zhou, Hui Zhou
1Kaiser Permanente Southern California, 100 S Los Robles Ave, 2nd Floor, Pasadena, CA 91101.
The American Journal of Managed Care
|September 12, 2025
Summary
Patients often adhere to statins for doctor
Area of Science:
- Cardiology and Primary Care
Background:
- Hypercholesterolemia management requires patient adherence to statin therapy and regular laboratory monitoring.
- Understanding patient and primary care physician (PCP) perspectives is crucial for effective safety-net program engagement.
Purpose of the Study:
- To explore patient and PCP perceptions of a safety-net program for hypercholesterolemia.
- To identify barriers and facilitators influencing patient engagement with the program, including statin adherence and lab test completion.
Main Methods:
- Cross-sectional telephone survey administered to 59 patients with hypercholesterolemia.
- Qualitative interviews conducted with 14 primary care physicians (PCPs).
Main Results:
- 86% of patients filled their statin prescription; adherence was driven by physician prescription, cholesterol reduction, and cardiovascular event prevention.
- Nonadherence reasons included lifestyle modification preference, medication concerns, and fear of adverse events.
- PCPs aware of the safety-net program (8/14) cited in-basket volume and lack of reminders as barriers; they identified patient fear of statins and forgetfulness as key adherence issues.
Conclusions:
- Enhancing patient knowledge of statins and educating PCPs on outreach programs can improve communication.
- Targeted interventions are needed to boost statin adherence and laboratory test completion in hypercholesterolemia management.
Related Concept Videos
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Peripheral Artery Disease III: Interprofessional Care
252
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
252
Health Literacy
5.2K
Health literacy is an individual's or a community's capacity to comprehend, receive, read, and use relevant healthcare information and services. The World Health Organization (WHO, 2018) defines health literacy as the cognitive and social skills that determine the ability of individuals to gain access to, understand, and use information in ways that promote and maintain good health. As a result, the WHO helps individuals manage long-term health concerns, participate in preventative...
5.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169

